Expand CANF Menu
CANF MENU

CANF Latest Press Releases

-- February 17, 2026 --

Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson Globe Newswire 7:00 AM

-- February 9, 2026 --

Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy Globe Newswire 7:00 AM

-- February 5, 2026 --

Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson Globe Newswire 7:00 AM

-- January 20, 2026 --

Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson Globe Newswire 7:00 AM

-- December 26, 2025 --

Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction Globe Newswire 7:00 AM

-- December 23, 2025 --

Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change Globe Newswire 4:46 PM

-- December 16, 2025 --

Can-Fite Provides Update on Clinical and Financial Status Globe Newswire 9:19 AM

-- November 26, 2025 --

Can-Fite's Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference Globe Newswire 7:00 AM

-- November 24, 2025 --

Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference Globe Newswire 7:00 AM

-- November 20, 2025 --

Can-Fite's CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil Globe Newswire 7:00 AM

-- November 18, 2025 --

Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes